期刊
INORGANIC CHEMISTRY
卷 55, 期 12, 页码 5983-5992出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.inorgchem.6b00476
关键词
-
资金
- Australian Research Council [FT120100926, FT130100838, DP130100816]
- ERC [247460]
- EPSRC [EP/F042159/1]
- EPSRC (MOAC)
- Science City (AWM/ERDF)
- European Union [627113]
- EPSRC [EP/F042159/1] Funding Source: UKRI
- MRC [G0701062] Funding Source: UKRI
- Engineering and Physical Sciences Research Council [EP/F042159/1] Funding Source: researchfish
- Medical Research Council [G0701062] Funding Source: researchfish
We report a detailed study of a promising photo-activatable metal-based anticancer prodrug candidate, trans,trans,trans-[Pt(N-3)(2)(OH)(2)(py)(2)] (Cl; py = pyridine), using vibrational spectroscopic techniques. Attenuated total reflection Fourier transform infrared (ATR-FTIR), Raman, and synchrotron radiation far-IR (SR-FIR) spectroscopies were applied to obtain highly resolved ligand and Pt-ligand vibrations for Cl and its precursors (trans[Pt(N-3)(2)(py)(2)] (C2) and trans-[PtCl2(py)(2)] (C3)). Distinct IR- and Raman-active vibrational modes were assigned with the aid of density functional theory calculations, and trends in the frequency shifts as a function of changing Pt coordination environment were determined and detailed for the first time. The data provide the ligand and Pt-ligand (azide, hydroxide, pyridine) vibrational signatures for Cl in the mid- and far-IR region, which will provide a basis for the better understanding of the interaction of Cl with biomolecules.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据